The association between macronutrients intake and myopia risk: a systematic review and meta-analysis.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 09 01 2024
accepted: 21 10 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Dietary factors have been suggested as potential risk factors for myopia, but research findings on this relationship are inconclusive. The potential predisposing or protective role of macronutrient (carbohydrate, protein, fat) intake in the development of myopia was systematically reviewed, followed by data synthesis by meta-analysis. A systematic search was conducted in PubMed, Web of Science, Scopus, and Google Scholar up to the end of June 2023 to identify all relevant studies. All observational studies that assessed the relationship between macronutrient intake with myopia, axial length (AL) of eyes and spherical equivalent refractive error (SE) on individuals younger than 18 years old were included. After removing duplicates and screening studies, four studies were included in the systematic review and meta-analysis. Pooled odds ratios regarding the association between myopia development and nutritional intake were 1.01 (95% CI: 0.94, 1.08), 0.97 (95% CI: 0.86, 1.08), and 0.99 (95% CI: 0.83, 1.18) for carbohydrates, proteins, and fats, respectively, indicating no significant associations. Intake of carbohydrates, proteins, and fats was not significantly associated with either SE or AL. Intake of carbohydrates, fats, or proteins did not influence the risk of myopia. The relationship between the intake of other macronutrients and myopia is suggested to be scrutinized in future studies. The systematic review protocol was registered on PROSPERO (registration number: CRD42024541369).

Sections du résumé

BACKGROUND BACKGROUND
Dietary factors have been suggested as potential risk factors for myopia, but research findings on this relationship are inconclusive. The potential predisposing or protective role of macronutrient (carbohydrate, protein, fat) intake in the development of myopia was systematically reviewed, followed by data synthesis by meta-analysis.
METHODS METHODS
A systematic search was conducted in PubMed, Web of Science, Scopus, and Google Scholar up to the end of June 2023 to identify all relevant studies. All observational studies that assessed the relationship between macronutrient intake with myopia, axial length (AL) of eyes and spherical equivalent refractive error (SE) on individuals younger than 18 years old were included.
RESULTS RESULTS
After removing duplicates and screening studies, four studies were included in the systematic review and meta-analysis. Pooled odds ratios regarding the association between myopia development and nutritional intake were 1.01 (95% CI: 0.94, 1.08), 0.97 (95% CI: 0.86, 1.08), and 0.99 (95% CI: 0.83, 1.18) for carbohydrates, proteins, and fats, respectively, indicating no significant associations. Intake of carbohydrates, proteins, and fats was not significantly associated with either SE or AL.
CONCLUSIONS CONCLUSIONS
Intake of carbohydrates, fats, or proteins did not influence the risk of myopia. The relationship between the intake of other macronutrients and myopia is suggested to be scrutinized in future studies.
REGISTRATION BACKGROUND
The systematic review protocol was registered on PROSPERO (registration number: CRD42024541369).

Identifiants

pubmed: 39472829
doi: 10.1186/s12886-024-03738-6
pii: 10.1186/s12886-024-03738-6
doi:

Substances chimiques

Dietary Carbohydrates 0

Types de publication

Journal Article Systematic Review Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

472

Subventions

Organisme : Isfahan University of Medical Sciences
ID : 1400179

Informations de copyright

© 2024. The Author(s).

Références

Sci Rep. 2019 Mar 5;9(1):3517
pubmed: 30837544
Adv Ophthalmol Pract Res. 2021 Nov 13;1(2):100010
pubmed: 37846322
Cureus. 2022 Aug 26;14(8):e28444
pubmed: 36176879
Lancet. 1958 May 31;1(7031):1152-5
pubmed: 13550953
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6779-87
pubmed: 26567790
J Optom. 2021 Apr-Jun;14(2):224-225
pubmed: 33402285
Acta Ophthalmol Scand. 2002 Apr;80(2):125-35
pubmed: 11952477
BMC Ophthalmol. 2023 Jan 2;23(1):1
pubmed: 36593443
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2903-10
pubmed: 18579757
Clin Exp Optom. 2018 Sep;101(5):692-699
pubmed: 29577442
Ophthalmic Physiol Opt. 2022 Mar;42(2):319-326
pubmed: 34862645
Bull World Health Organ. 2009 Jun;87(6):431-7
pubmed: 19565121
Metabolism. 2000 Jan;49(1):1-5
pubmed: 10647056
Am J Ophthalmol. 2014 Jan;157(1):9-25.e12
pubmed: 24099276
Nutr Res. 2015 Feb;35(2):107-17
pubmed: 25636674
Exp Eye Res. 2013 Sep;114:58-68
pubmed: 23644222
Nutrients. 2023 Apr 18;15(8):
pubmed: 37111164
Wei Sheng Yan Jiu. 2022 Sep;51(5):713-719
pubmed: 36222031
Nutrients. 2023 Mar 17;15(6):
pubmed: 36986186
J Nutr. 2009 Jan;139(1):1-4
pubmed: 19056664
JAMA Ophthalmol. 2024 Feb 1;142(2):115-122
pubmed: 38175641
Mol Biol Rep. 2015 Jan;42(1):303-10
pubmed: 25266237
Lancet. 2012 May 5;379(9827):1739-48
pubmed: 22559900
Oxid Med Cell Longev. 2015;2015:750637
pubmed: 25922643
PLoS One. 2012;7(12):e52668
pubmed: 23300738
Ophthalmology. 2016 May;123(5):1036-42
pubmed: 26875007
Diabetes. 2007 Jul;56(7):1761-72
pubmed: 17456850
Retina. 2017 Dec;37(12):2347-2351
pubmed: 28590964
Biochem J. 1999 Nov 15;344 Pt 1:109-16
pubmed: 10548540
Ophthalmology. 2010 May;117(5):993-997.e4
pubmed: 20079928
Diabetes Care. 2018 Aug;41(8):1732-1739
pubmed: 29844096
Med Hypotheses. 2016 May;90:32-40
pubmed: 27063082
Cell Metab. 2015 Oct 6;22(4):658-68
pubmed: 26321659
BMC Ophthalmol. 2020 Aug 18;20(1):337
pubmed: 32811458
Am J Clin Nutr. 2006 Jul;84(1):70-6; quiz 266-7
pubmed: 16825683
Nutrients. 2023 Aug 08;15(16):
pubmed: 37630690
Front Pediatr. 2023 Apr 17;11:1122773
pubmed: 37138572
Optom Vis Sci. 1996 Oct;73(10):638-43
pubmed: 8916134

Auteurs

Soraya Massoudi (S)

Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Fatemeh Azizi-Soleiman (F)

School of Health, Arak University of Medical Sciences, Arak, Iran.

Maryam Yazdi (M)

Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Mohammadamin Meghdadi Esfahani (M)

Faculty of Health Sciences, Queen's University, Kingston, ON, K7L 3N6, Canada.

Motahar Heidari-Beni (M)

Department of Nutrition, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Hezarjerib St, Isfahan, Iran. heidari.motahar@gmail.com.

Roya Kelishadi (R)

Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran. roya.kelishadi@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH